My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Results: 1 to 20 of 366

1.

ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients.

Fehm T, Krawczyk N, Solomayer EF, Becker-Pergola G, Dürr-Störzer S, Neubauer H, Seeger H, Staebler A, Wallwiener D, Becker S.

Breast Cancer Res. 2008;10(5):R76. Epub 2008 Sep 15.PMID: 18793387 [PubMed - indexed for MEDLINE]Related articlesFree article

2.

Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells.

Fehm T, Hoffmann O, Aktas B, Becker S, Solomayer EF, Wallwiener D, Kimmig R, Kasimir-Bauer S.

Breast Cancer Res. 2009;11(4):R59. Epub 2009 Aug 10.PMID: 19664291 [PubMed - indexed for MEDLINE]Related articlesFree article

3.

Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients.

Solomayer EF, Becker S, Pergola-Becker G, Bachmann R, Krämer B, Vogel U, Neubauer H, Wallwiener D, Huober J, Fehm TN.

Breast Cancer Res Treat. 2006 Jul;98(2):179-84. Epub 2006 Mar 22.PMID: 16552629 [PubMed - indexed for MEDLINE]Related articles

4.

Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer.

Daskalaki A, Agelaki S, Perraki M, Apostolaki S, Xenidis N, Stathopoulos E, Kontopodis E, Hatzidaki D, Mavroudis D, Georgoulias V.

Br J Cancer. 2009 Aug 18;101(4):589-97. Epub 2009 Jul 21.PMID: 19623181 [PubMed - indexed for MEDLINE]Related articles

5.

Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma.

Bièche I, Girault I, Urbain E, Tozlu S, Lidereau R.

Breast Cancer Res. 2004;6(3):R252-63. Epub 2004 Mar 26.PMID: 15084249 [PubMed - indexed for MEDLINE]Related articlesFree article

6.

On the way to specifically targeting minimal residual disease?

Gebauer G.

Breast Cancer Res. 2008;10(5):112. Epub 2008 Oct 7.PMID: 18947365 [PubMed - indexed for MEDLINE]Related articlesFree article

7.

A candidate molecular signature associated with tamoxifen failure in primary breast cancer.

Vendrell JA, Robertson KE, Ravel P, Bray SE, Bajard A, Purdie CA, Nguyen C, Hadad SM, Bieche I, Chabaud S, Bachelot T, Thompson AM, Cohen PA.

Breast Cancer Res. 2008;10(5):R88. Epub 2008 Oct 17.PMID: 18928543 [PubMed - indexed for MEDLINE]Related articlesFree article

8.

Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigen.

Schindlbeck C, Jeschke U, Schulze S, Karsten U, Janni W, Rack B, Sommer H, Friese K.

Histochem Cell Biol. 2005 Jun;123(6):631-7. Epub 2005 May 12.PMID: 15889266 [PubMed - indexed for MEDLINE]Related articles

9.

Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer.

Rexhepaj E, Brennan DJ, Holloway P, Kay EW, McCann AH, Landberg G, Duffy MJ, Jirstrom K, Gallagher WM.

Breast Cancer Res. 2008;10(5):R89. Epub 2008 Oct 23.PMID: 18947395 [PubMed - indexed for MEDLINE]Related articlesFree article

10.

A summary of two clinical studies on tumor cell dissemination in primary and metastatic breast cancer: methods, prognostic significance and implication for alternative treatment protocols (Review).

Kasimir-Bauer S, Oberhoff C, Schindler AE, Seeber S.

Int J Oncol. 2002 May;20(5):1027-34. Review.PMID: 11956600 [PubMed - indexed for MEDLINE]Related articles

11.

HER2 status on persistent disseminated tumor cells after adjuvant therapy may differ from initial HER2 status on primary tumor.

Krawczyk N, Banys M, Neubauer H, Solomayer EF, Gall C, Hahn M, Becker S, Bachmann R, Wallwiener D, Fehm T.

Anticancer Res. 2009 Oct;29(10):4019-24.PMID: 19846945 [PubMed - indexed for MEDLINE]Related articles

12.

Inhibition of skeletal metastasis by ectopic ERalpha expression in ERalpha-negative human breast cancer cell lines.

Bandyopadhyay A, Wang L, Chin SH, Sun LZ.

Neoplasia. 2007 Feb;9(2):113-8.PMID: 17356707 [PubMed - indexed for MEDLINE]Related articlesFree article

13.

Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancer.

Wimberger P, Heubner M, Otterbach F, Fehm T, Kimmig R, Kasimir-Bauer S.

Gynecol Oncol. 2007 Nov;107(2):331-8. Epub 2007 Aug 31.PMID: 17764727 [PubMed - indexed for MEDLINE]Related articles

14.

A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study.

Novelli F, Milella M, Melucci E, Di Benedetto A, Sperduti I, Perrone-Donnorso R, Perracchio L, Venturo I, Nisticò C, Fabi A, Buglioni S, Natali PG, Mottolese M.

Breast Cancer Res. 2008;10(5):R74. Epub 2008 Sep 4.PMID: 18771580 [PubMed - indexed for MEDLINE]Related articlesFree article

15.

miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.

Kondo N, Toyama T, Sugiura H, Fujii Y, Yamashita H.

Cancer Res. 2008 Jul 1;68(13):5004-8.PMID: 18593897 [PubMed - indexed for MEDLINE]Related articlesFree article

16.

An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells.

Duss S, André S, Nicoulaz AL, Fiche M, Bonnefoi H, Brisken C, Iggo RD.

Breast Cancer Res. 2007;9(3):R38.PMID: 17573968 [PubMed - indexed for MEDLINE]Related articlesFree article

17.

Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen.

Schindlbeck C, Stellwagen J, Jeschke U, Karsten U, Rack B, Janni W, Jückstock J, Tulusan A, Sommer H, Friese K.

Clin Exp Metastasis. 2008;25(3):233-40. Epub 2008 Jan 10.PMID: 18185913 [PubMed - indexed for MEDLINE]Related articles

18.

Association of oestrogen receptor beta 2 (ER beta 2/ER beta cx) with outcome of adjuvant endocrine treatment for primary breast cancer--a retrospective study.

Vinayagam R, Sibson DR, Holcombe C, Aachi V, Davies MP.

BMC Cancer. 2007 Jul 18;7:131.PMID: 17640362 [PubMed - indexed for MEDLINE]Related articlesFree article

19.

Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy.

Becker S, Becker-Pergola G, Wallwiener D, Solomayer EF, Fehm T.

Breast Cancer Res Treat. 2006 May;97(1):91-6. Epub 2005 Dec 1.PMID: 16319975 [PubMed - indexed for MEDLINE]Related articles

20.

Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.

Bidard FC, Vincent-Salomon A, Gomme S, Nos C, de Rycke Y, Thiery JP, Sigal-Zafrani B, Mignot L, Sastre-Garau X, Pierga JY; Institut Curie Breast Cancer Study Group.

Clin Cancer Res. 2008 Jun 1;14(11):3306-11.PMID: 18519757 [PubMed - indexed for MEDLINE]Related articlesFree article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

You are here: NCBI > Literature > PubMed
Write to the Help Desk